PE20001432A1 - Agonistas de 5-ht1f - Google Patents
Agonistas de 5-ht1fInfo
- Publication number
- PE20001432A1 PE20001432A1 PE2000000153A PE0001532000A PE20001432A1 PE 20001432 A1 PE20001432 A1 PE 20001432A1 PE 2000000153 A PE2000000153 A PE 2000000153A PE 0001532000 A PE0001532000 A PE 0001532000A PE 20001432 A1 PE20001432 A1 PE 20001432A1
- Authority
- PE
- Peru
- Prior art keywords
- nr3r4
- alkyl
- formula
- group
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12201699P | 1999-02-26 | 1999-02-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20001432A1 true PE20001432A1 (es) | 2000-12-18 |
Family
ID=22400069
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000000153A PE20001432A1 (es) | 1999-02-26 | 2000-02-24 | Agonistas de 5-ht1f |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1155020B1 (de) |
| JP (1) | JP2002537398A (de) |
| KR (1) | KR20010102355A (de) |
| AR (1) | AR026856A1 (de) |
| AT (1) | ATE258935T1 (de) |
| AU (1) | AU3354000A (de) |
| BR (1) | BR0008479A (de) |
| CA (1) | CA2371784A1 (de) |
| CO (1) | CO5150234A1 (de) |
| DE (1) | DE60008073T2 (de) |
| EA (1) | EA200100918A1 (de) |
| ES (1) | ES2214256T3 (de) |
| HU (1) | HUP0200245A2 (de) |
| ID (1) | ID30056A (de) |
| IL (1) | IL144355A0 (de) |
| NO (1) | NO20014127L (de) |
| PE (1) | PE20001432A1 (de) |
| PL (1) | PL350864A1 (de) |
| TR (1) | TR200102436T2 (de) |
| WO (1) | WO2000050426A2 (de) |
| ZA (1) | ZA200106109B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI263497B (en) | 2002-03-29 | 2006-10-11 | Lilly Co Eli | Pyridinoylpiperidines as 5-HT1F agonists |
| ES2388547T3 (es) | 2003-04-18 | 2012-10-16 | Eli Lilly And Company | Compuestos de (piperidiniloxi)fenilo, (piperidiniloxi)piridinilo, (piperidinilsulfanil)fenilo y (piperidinilsulfanil)piridinilo como agonistas de 5-HT 1F |
| UA82711C2 (en) | 2003-09-12 | 2008-05-12 | Эли Лилли Энд Компани | Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists |
| JP2007516266A (ja) | 2003-12-17 | 2007-06-21 | イーライ リリー アンド カンパニー | ５−ｈｔ１ｆアゴニストとしての置換（４−アミノシクロヘキセン−１−イル）フェニルおよび（４−アミノシクロヘキセン−１−イル）ピリジニル化合物 |
| US8697876B2 (en) | 2010-04-02 | 2014-04-15 | Colucid Pharmaceuticals, Inc. | Compositions and methods of synthesis of pyridinolypiperidine 5-HT1F agonists |
| EP2940022B1 (de) * | 2014-04-30 | 2020-09-02 | Masarykova Univerzita | Furopyridinen als Inhibitoren von Proteinkinasen |
| TWI829107B (zh) | 2019-07-09 | 2024-01-11 | 美商美國禮來大藥廠 | 大規模製備2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲醯胺半琥珀酸鹽的方法及中間體，以及2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲醯胺醋酸鹽之製備 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU702322B2 (en) * | 1995-03-20 | 1999-02-18 | Eli Lilly And Company | 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists |
| FR2732969B1 (fr) * | 1995-04-14 | 1997-05-16 | Adir | Nouveaux composes pyridiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| AU4074897A (en) * | 1996-09-18 | 1998-04-14 | Eli Lilly And Company | A method for the prevention of migraine |
-
2000
- 2000-02-11 TR TR2001/02436T patent/TR200102436T2/xx unknown
- 2000-02-11 DE DE60008073T patent/DE60008073T2/de not_active Expired - Fee Related
- 2000-02-11 IL IL14435500A patent/IL144355A0/xx unknown
- 2000-02-11 AU AU33540/00A patent/AU3354000A/en not_active Abandoned
- 2000-02-11 PL PL00350864A patent/PL350864A1/xx not_active Application Discontinuation
- 2000-02-11 EP EP00911678A patent/EP1155020B1/de not_active Expired - Lifetime
- 2000-02-11 AT AT00911678T patent/ATE258935T1/de not_active IP Right Cessation
- 2000-02-11 WO PCT/US2000/002505 patent/WO2000050426A2/en not_active Application Discontinuation
- 2000-02-11 BR BR0008479-4A patent/BR0008479A/pt not_active Application Discontinuation
- 2000-02-11 EA EA200100918A patent/EA200100918A1/ru unknown
- 2000-02-11 ES ES00911678T patent/ES2214256T3/es not_active Expired - Lifetime
- 2000-02-11 JP JP2000601006A patent/JP2002537398A/ja not_active Withdrawn
- 2000-02-11 HU HU0200245A patent/HUP0200245A2/hu unknown
- 2000-02-11 KR KR1020017010743A patent/KR20010102355A/ko not_active Application Discontinuation
- 2000-02-11 CA CA002371784A patent/CA2371784A1/en not_active Abandoned
- 2000-02-11 ID IDW00200101739D patent/ID30056A/id unknown
- 2000-02-24 PE PE2000000153A patent/PE20001432A1/es not_active Application Discontinuation
- 2000-02-24 CO CO00013084A patent/CO5150234A1/es unknown
- 2000-02-24 AR ARP000100791A patent/AR026856A1/es unknown
-
2001
- 2001-07-25 ZA ZA200106109A patent/ZA200106109B/en unknown
- 2001-08-24 NO NO20014127A patent/NO20014127L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200106109B (en) | 2002-07-25 |
| CA2371784A1 (en) | 2000-08-31 |
| EP1155020A2 (de) | 2001-11-21 |
| ES2214256T3 (es) | 2004-09-16 |
| PL350864A1 (en) | 2003-02-10 |
| CO5150234A1 (es) | 2002-04-29 |
| EA200100918A1 (ru) | 2002-02-28 |
| AR026856A1 (es) | 2003-03-05 |
| JP2002537398A (ja) | 2002-11-05 |
| DE60008073D1 (de) | 2004-03-11 |
| TR200102436T2 (tr) | 2002-06-21 |
| WO2000050426A3 (en) | 2000-12-21 |
| ATE258935T1 (de) | 2004-02-15 |
| IL144355A0 (en) | 2002-05-23 |
| NO20014127D0 (no) | 2001-08-24 |
| EP1155020B1 (de) | 2004-02-04 |
| WO2000050426A2 (en) | 2000-08-31 |
| AU3354000A (en) | 2000-09-14 |
| ID30056A (id) | 2001-11-01 |
| NO20014127L (no) | 2001-08-24 |
| KR20010102355A (ko) | 2001-11-15 |
| DE60008073T2 (de) | 2004-08-05 |
| HUP0200245A2 (en) | 2002-06-29 |
| BR0008479A (pt) | 2002-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP034475A (es) | Derivados de 4-fenil-piridin como antagonistas del receptor de neuroquinina-1 | |
| PE20030440A1 (es) | Fenilsulfonamidas como antagonistas de ccr3 | |
| DE3876211D1 (de) | Benzothiadiazole und ihre verwendung in verfahren und mitteln gegen pflanzenkrankheiten. | |
| ES2127919T3 (es) | 4-amino-piridinas, procedimiento para su preparacion, asi como medicamentos que contienen estos compuestos. | |
| PE20020476A1 (es) | Derivados de glucopiranosiloxibencilbenceno y composiciones farmaceuticas que comprenden los mismos | |
| CO2019011604A2 (es) | Compuestos inhibidores de vmat2, composiciones y métodos relativos a los mismos | |
| PA8522001A1 (es) | Pro - farmacos de derivados de 4- fenil - piridin. | |
| PE46597A1 (es) | Agonista de estrogeno | |
| PE20040197A1 (es) | Pirazolopiridinas sustituidas con carbamato | |
| CO5150227A1 (es) | Compuestos de triazol y su utilizacion | |
| PE20050130A1 (es) | Compuestos organicos | |
| AR015712A1 (es) | Derivados de 3,4-dihidro-tieno[2,3-d]pirimidina-3-sustituidos y su uso para la preparacion de composiciones farmaceuticas | |
| PE20060457A1 (es) | Derivados de difenil eter como antagonistas de los receptores 5ht2 | |
| ECSP066548A (es) | 4-anilino-3-quinolincarbonitrilos para el tratamiento de leucemia mielogena cronica | |
| PE20001432A1 (es) | Agonistas de 5-ht1f | |
| ES2058265T3 (es) | Piperidinas antagonistas de opiaceos. | |
| PE20040907A1 (es) | Derivados de anilinopirazol | |
| AR050341A1 (es) | Compuestos derivados de piperidina, composicion farmaceutica en base al compuesto y su uso para preparar medicamentos | |
| AR070885A1 (es) | Compuestos de azaindol para el tratamiento de trastornos del sistema nervioso central | |
| PA8561501A1 (es) | Lactamas como antagonistas de taquiquininas | |
| AR067454A1 (es) | Derivados de indano- amina, su preparacion y uso como medicamentos | |
| BRPI0416228A (pt) | uso de inibidores glucosidade para terapia de mucovisidose | |
| AR247380A1 (es) | Procedimiento para preparar derivados de n-aminobutil n-fenil arilamidas | |
| ECSP045121A (es) | Agonistas del receptor activado por proliferador de peroxisoma | |
| ES2186212T3 (es) | Compuesto farmaceutico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |